Critical nodes in signalling pathways: insights into insulin action
The DOI matches its Crossref record; 127 of the 129 references it cites were found in a registry or an index.
Abstract
Physiologically important cell-signalling networks are complex, and contain several points of regulation, signal divergence and crosstalk with other signalling cascades. Here, we use the concept of 'critical nodes' to define the important junctions in these pathways and illustrate their unique role using insulin signalling as a model system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skeletal muscle, insulin binds to the insulin receptor leading to phosphorylation of three key tyrosine molecules on the insulin receptor. Once the insulin receptor has been phosphorylated, insulin receptor substrate (IRS)-1 moves to the cell membrane and becomes phosphorylated on contiguous tyrosine molecules.”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [25]
In the citing paper
“Reduced phosphorylation of the PI3K/Akt pathway is a hallmark of IR in PCOS patients10–12.”
From Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials (2025) · cites this paper as [10]
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [11]
Citations
Cites
2 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272
Self-citationRetractedUeki, K., Fruman, D. A., Yballe, C. M., Fasshauer, M., Klein, J., Asano, T., Cantley, L. C., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305602200 · Cited by 208
Self-citationRetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 2×
“The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“For instance, the phosphorylation of Ser307 of IRS1, which is located in the PTB domain, has been correlated with negative regulation of insulin signallin”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“Recently, the activation of nuclear factor (NF)-κB-mediated pathways also have been shown to inhibit insulin signalling through enhanced serine phosphorylation of IRS1 (Ref”
BackgroundElchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954 · cited 1×
“Also, the p85/p110–PI3K complex binds to Ras, linking two pathways that are normally considered to be distinc”
Background
Cited by
Items 701–800 of 1,013
Westley, R., & May, F. E. B. (2013) · International Journal of Endocrinology · doi:10.1155/2013/632461 · Cited by 70
“Insulin can stimulate nonmetabolic effects via interaction with the insulin receptor and activation of the MAPK pathway [130].”
BackgroundKim, K., Kim, K. H., & Cheong, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008649 · Cited by 68
“been correlated with negative regulation of insulin signalling [11,34].”
BackgroundThe Multiple Facets of the Fat Tissue
Rocha, V. Z., & Libby, P. (2008) · Thyroid · doi:10.1089/thy.2007.0296 · Cited by 59
Rivas, D. A., Yaspelkis, B. B., Hawley, J. A., & Lessard, S. J. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0202 · Cited by 66
“Accordingly, impaired insulin signalling has been implicated in several disease states including type 2 diabetes (Zamboni et al. 2005, Taniguchi et al. 2006).”
InfluentialAhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle
Kim, Y., Seok, S., Byun, S., Kong, B., Zhang, Y., Guo, G. L., Xie, W., Ma, J., KEMPER, B. W., & Kemper, J. K. (2018) · Nature Communications · doi:10.1038/s41467-018-03060-y · Cited by 62
Murtha, M. J., Eichler, T. E., Bender, K., Metheny, J., Li, B., Schwaderer, A. L., Mosquera, C., James, C. L., Schwartz, L., Becknell, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98595 · Cited by 59
“Although the causes of insulin resistance are unclear, key mechanisms include disrupted IR signaling or decreased IR expression (8, 9).”
BackgroundCheng, F., Han, L., Xiao, Y., Pan, C., Li, Y., Ge, X., Zhang, Y., Yan, S., & Wang, M. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01253 · Cited by 59
Tu, Z., Argmann, C., Wong, K. K., Mitnaul, L. J., Edwards, S., Sach, I. C., Zhu, J., & Schadt, E. E. (2009) · Genome Research · doi:10.1101/gr.087890.108 · Cited by 59
“Insulin-dependent anti-lipolysis based siRNA screen The anti-lipolysis screen was developed using 3T3-L1 cells that had been differentiated as described before (Thompson et al. 2004).”
MethodCellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 69
Haider, N., Lebastchi, J., Jayavelu, A. K., Batista, T. M., Pan, H., Dreyfuss, J. M., Carcamo‐Orive, I., Knowles, J. W., Mann, M., & Kahn, C. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151818 · Cited by 58
“As a result, 2 major downstream signaling cascades are initiated: the Ras/MAP kinase pathway and the PI3K/Akt pathway (10, 11).”
Self-citationSelective insulin resistance in hepatocyte senescence
Aravinthan, A., Challis, B., Shannon, N., Hoare, M., Heaney, J., & Alexander, G. J. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.025 · Cited by 58
Boucher, J., Charalambous, M., Zarse, K., Mori, M. A., Kleinridders, A., Ristow, M., Ferguson‐Smith, A. C., & Kahn, C. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415475111 · Cited by 63
“Cold Spring Harb Perspect Biol 6(1):409.”
BackgroundSelf-citationSun, X., Meng, H., Shi, D., Xu, L., Zhang, L., Chen, Z. B., Feng, X., Lu, R., & Ren, X. Y. (2008) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2008.01131.x · Cited by 65
Insulin Induces REDD1 Expression through Hypoxia-inducible Factor 1 Activation in Adipocytes
Regazzetti, C., Bost, F., Le Marchand-Brustel, Y., Tanti, J.-F., & Giorgetti-Peraldi, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047688 · Cited by 57
Xu, T., Guo, L., Wang, P., Song, J., Le, Y., Viollet, B., & Miao, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051217 · Cited by 61
“As GLUT4 plays an important role in insulin-stimulated glucose uptake [54], observing GLUT4 in C2C12 myotubes and the above animal models may contribute to understanding the mechanism of this effect.”
BackgroundStockman, B. J., Kothe, M., Kohls, D., Weibley, L., Connolly, B. J., Sheils, A. L., Cao, Q., Cheng, A. C., Yang, L. P. H., Kamath, A. V., et al. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00768.x · Cited by 62
“Aberrant activation of this pathway because of genetic mutations of essential signalling proteins has been associated with human diseases including cancer and diabetes (3,4).”
BackgroundLanuza-Masdeu, J., Arévalo, M. I., Vila, C., Barberà, A., Gomis, R., & Caelles, C. (2013) · Diabetes · doi:10.2337/db12-1097 · Cited by 58
“In contrast, in normal conditions, activated InsR triggers IRS-1 tyrosine phosphorylation, thus allowing the recruitment and activation of downstream effectors, such as the phosphatidylinositol 3-kinase–Akt cascade (5).”
Optogenetic activation reveals distinct roles of PIP3 and Akt in adipocyte insulin action
Xu, Y., Nan, D., Fan, J., Bogan, J. S., & Toomre, D. K. (2016) · Journal of Cell Science · doi:10.1242/jcs.174805 · Cited by 64
“As an important control, ERK1/2 (also known as MAPK3 and MAPK1), which is a downstream target of activated insulin receptor (Taniguchi et al., 2006),was phosphorylated only by insulin and not in response to blue LED light (Fig.”
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
Manzella, L., Massimino, M., Stella, S., Tirrò, E., Pennisi, M. S., Martorana, F., Motta, G., Vitale, S. R., Puma, A., Romano, C., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133258 · Cited by 61
Compartmentalised MAPK Pathways
Brown, M. D., & Sacks, D. B. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_9 · Cited by 59
Small EPIDERMAL PATTERNING FACTOR-LIKE2 peptides regulate awn development in rice
Xiong, L., Huang, Y., Liu, Z., Li, C., Yu, H., Shahid, M. Q., Lin, Y., Qiao, X., Xiao, J., Gray, J. E., et al. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac278 · Cited by 64
Wu, C., Wu, S., Liao, C., Teng, C., Wu, Y., & Kuo, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00921.x · Cited by 57
“It has been shown that the Ca2+-insensitive, novel isoforms of PKC (d and q) and the Ca2+/DAG insensitive, atypical forms of PKC (z) can be phosphorylated and activated by PDK-1 in a PI3K-dependent manner (Le Good et al., 1998; Villalba et al., 2002; Frey et al., 2006; Taniguchi et al., 2006).”
BackgroundSingle-Cell Profiling Reveals the Origin of Phenotypic Variability in Adipogenesis
Le, T. T., & Cheng, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005189 · Cited by 57
“It is important to point out that these variables are part of an insulin signaling cascade (Fig. 1A) [ 44 ].”
BackgroundProtein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation
Bettaieb, A., Bakke, J., Nagata, N., Matsuo, K., Xi, Y., Liu, S., AbouBechara, D., Melhem, R., Stanhope, K. L., Cummings, B. P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441469 · Cited by 59
Heni, M., Hennenlotter, J., Scharpf, M., Lutz, S. Z., Schwentner, C., Todenhöfer, T., Schilling, D., Kühs, U., Gerber, V., Machicao, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050953 · Cited by 57
“IGF-1 receptor), insulin receptor substrate (IRS)-1 and IRS-2 are crucial to further communicate signals from these receptors [12,13].”
BackgroundCaperuto, L. C., Anhê, G. F., Cambiaghi, T. D., Akamine, E. H., Buonfiglio, D. D. C., Cipolla‐Neto, J., Curi, R., & Bordin, S. A. (2008) · Endocrinology · doi:10.1210/en.2008-0655 · Cited by 70
“Its activation is involved in both suppression of hepatic glucose production and skeletal muscle glucose uptake (51).”
BackgroundPilot-Storck, F., Chopin, E., Rual, J.-F., Baudot, A., Dobrokhotov, P., Robinson-Rechavi, M., Brun, C., Cusick, M. E., Hill, D. E., Schaeffer, L., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900568-mcp200 · Cited by 57
“Cloning of PI3K-mTOR Pathway Components—The PI3KmTOR pathway is multimodular, each functional module integrating various inputs for downstream effectors (1, 2).”
BackgroundKidd, L. B., Schabbauer, G., Luyendyk, J. P., Holscher, T. D., Tilley, R. E., Tencati, M., & Mackman, N. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138891 · Cited by 57
“It is well established that insulin activates PI3K/Akt signaling in many cell types (Taniguchi et al., 2006).”
BackgroundHistone deacetylase regulates insulin signaling via two pathways in pancreatic β cells
Kawada, Y., Asahara, S., Sugiura, Y., Sato, A., Furubayashi, A., Kawamura, M., Bartolomé, A., Terashi, E., Takai, T., Kanno, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184435 · Cited by 58
Hu, J., Chen, J.-B., Cui, Y., Zhu, Y.-W., Ren, W.-B., Zhou, X., Liu, L.-F., Chen, H.-Q., & Zu, X.-B. (2018) · Medicine · doi:10.1097/md.0000000000011596 · Cited by 56
“6 Substrate-1 (IRS-1), which results in inactivation of downstream insulin-associated signaling pathways like PI3K-AKT/Protein Kinase B (PKB) and Ras-MAPK to inhibit tumor growth.([32,33]) In line with this mechanism, Wang et al([34]) demonstrated that human bladder cancer cells transfected with hsa-miR-96 inhibitor s…”
BackgroundPHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Roles for insulin-supported skeletal muscle growth1,2
Rhoads, R. P., Baumgard, L. H., El‐Kadi, S. W., & Zhao, L. D. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0110 · Cited by 63
“The ability of insulin to support multiple processes in an integrated fashion is supported by the numerous signaling pathways and multiple isoforms of signaling proteins with those pathways (Taniguchi et al., 2006).”
Biomarkers of dysfunctional visceral fat
Gugliucci, A. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.001 · Cited by 73
Chapter 13 Phosphorylation of IRS Proteins
Sun, X., & Liu, F. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00613-4 · Cited by 71
Participation of Akt, Menin, and p21 in Pregnancy-Induced β-Cell Proliferation
Hughes, E., & Huang, C. (2011) · Endocrinology · doi:10.1210/en.2010-1250 · Cited by 56
Maeno, Y., Li, Q., Park, K., Rask‐Madsen, C., Gao, B., Matsumoto, M., Liu, Y., Wu, I., White, M. F., Feener, E. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286591 · Cited by 65
Nogueira, L. M., Lavigne, J. A., Chandramouli, G. V. R., Lui, H., Barrett, J. C., & Hursting, S. D. (2012) · Cancer Medicine · doi:10.1002/cam4.23 · Cited by 56
“IGF-1 exerts its effects on cellular growth and metabolism, at least in part, through activation of the phosphatidylinositol 3-kinase (PI3K)/ Akt/mammalian target of rapamycin (mTOR) pathway [12, 13].”
BackgroundLiu, S., Xu, R., Gerin, I., Cawthorn, W. P., MacDougald, O. A., Chen, X., Saltiel, A. R., Koenig, R. J., & Xu, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095416 · Cited by 60
“Insulin stimulates glucose uptake, utilization and storage through binding to the IR, which triggers autophosphorylation of the IR b-subunit [18], activation of IRS-1 by tyrosine phosphorylation, and activation of downstream signaling through the phosphatidylinositol 3-kinase (PI3K)-Akt/ protein kinase B, Ras-mitogen-…”
BackgroundGalbo, T., Olsen, G. S., Quistorff, B., & Nishimura, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027424 · Cited by 56
Nelson, V. L., Jiang, Y., Dickman, K. G., Ballou, L. M., & Lin, R. Z. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00625.2013 · Cited by 62
“Phosphoinositide 3-kinase (PI3K) is activated in response to insulin treatment and plays a critical role in mediating metabolic responses to the hormone (52).”
BackgroundWullschleger, S., Wasserman, D. H., Gray, A., Sakamoto, K., & Alessi, D. R. (2011) · Biochemical Journal · doi:10.1042/bj20102012 · Cited by 64
“The PI3K (phosphoinositide 3-kinase) pathway plays a central role in regulating most cellular responses to insulin [1].”
BackgroundChen, X., Wang, L., Fan, S., Song, S., Min, H., Wu, Y., He, X., Liang, Q., Wang, Y., Yi, L., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.033 · Cited by 57
Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis
Machado‐Neto, J. A., Fenerich, B. A., Alves, A. P. N. R., Fernandes, J. C., Scopim‐Ribeiro, R., Coelho‐Silva, J. L., & Traina, F. (2018) · Clinics · doi:10.6061/clinics/2018/e566s · Cited by 59
“bind to various Src homology (SH2) domain-containing proteins, including PI3K, GRB2, SHP2, resulting in the activation of multiple signaling pathways, especially the PI3K/AKT/mTOR and MAPK pathways (19-23).”
BackgroundInsulin receptor substrate 2 is a negative regulator of memory formation
Irvine, E. E., Drinkwater, L., Radwanska, K., Al-Qassab, H., Smith, M. A., O'Brien, M., Kielar, C., Choudhury, A. I., Krauss, S., Cooper, J. D., et al. (2011) · Learning & Memory · doi:10.1101/lm.2111311 · Cited by 56
“This results in the engagement of various downstream signaling cascades, such as the phosphatidylinositol-3 kinase and MAP kinase pathways (White 2002; Taniguchi et al. 2006).”
Quantitative phosphoproteomic analysis of signaling network dynamics
White, F. M. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.06.006 · Cited by 55
“Current Opinion in Biotechnology 2008, 19:404–409 kinases and phosphatases has been linked to a vast number of pathologies, including cancer [1], autoimmune diseases [2], metabolic disorders [3], and pathogenic infections [4].”
BackgroundPOST-BURN HEPATIC INSULIN RESISTANCE IS ASSOCIATED WITH ENDOPLASMIC RETICULUM (ER) STRESS
Gauglitz, G. G., Halder, S. C., Boehning, D. F., Kulp, G. A., Herndon, D. N., Barral, J. M., & Jeschke, M. G. (2010) · Shock · doi:10.1097/shk.0b013e3181b2f439 · Cited by 56
“thus inhibiting insulin receptor signaling (35, 36).”
Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats
Zhao, Y., ZENG, D.-L., Xia, L., Zhang, S., Xu, L., Jiang, X., & Zhang, F. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1227 · Cited by 57
“…of bone formation through insulin receptor (IR), IGF-1 receptor (IGF-1R) and a common hybrid receptor, which could activate the insulin receptor substrate (IRS) proteins that regulate a variety of signaling pathways controlling cell proliferation, differentiation, apoptosis and metabolism (16).”
Boone, D. N., & Lee, A. V. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v17.i2.30 · Cited by 57
Lie, S., Morrison, J. L., Williams-Wyss, O., Suter, C. M., Humphreys, D. T., Ozanne, S. E., Zhang, S., MacLaughlin, S. M., Kleemann, D. O., Walker, S. K., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00553.2013 · Cited by 57
“Interestingly, there was a positive relationship between miR339-5p expression and PI3K (p110 ) (P 0.05, r2 0.36), PTEN (P 0.05, r2 0.31), Akt2 (P 0.01, r2 0.42), and PEPCK-C (P 0.01, r2 0.53) protein abundance in singletons and twins (data not shown).”
BackgroundInfluentialPAQR3 Modulates Insulin Signaling by Shunting Phosphoinositide 3-Kinase p110α to the Golgi Apparatus
Wang, X., Wang, L., Zhu, L., Pan, Y., Xiao, F., Liu, W., Wang, Z., Guo, F., Liu, Y., Thomas, W. G., et al. (2012) · Diabetes · doi:10.2337/db12-0244 · Cited by 59
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
Tomasetti, M., Amati, M., Santarelli, L., & Neužil, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050754 · Cited by 59
“IRS1 activated by IGF-IR recruits intracellular proteins containing SH2 domains, leading to activation of the PI3K-AKT, which is responsible for most of the metabolic actions of insulin, FOXO1 pathways [123].”
BackgroundCross‐talk of healthy and impaired human tissues for dissection of disease pathogenesis
Zoso, A., Zambon, A., Gagliano, O., Giulitti, S., Prevedello, L., Fadini, G. P., Luni, C., & Elvassore, N. (2018) · Biotechnology Progress · doi:10.1002/btpr.2766 · Cited by 55
“Insulin signaling pathway within muscle cells is a complex network of protein interactions that is activated in response to the presence of high concentrations of extra-cellular insulin, which is produced by the pancreas.(26) In this work, we focus on the specific subnetwork of the insulin signaling pathway shown in F…”
BackgroundMethodPhosphoproteome profiling uncovers a key role for CDKs in TNF signaling
Tanzer, M. C., Bludau, I., Stafford, C. A., Hornung, V., & Mann, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26289-6 · Cited by 58
Ouyang, H., He, X., Li, G., Xu, H., Jia, X., Nie, Q., & Zhang, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160716242 · Cited by 62
“FOXO3 is an important member of the transcriptional regulatory factor FOXO family; it was found involved in insulin and the IGF1 signaling pathway, which has an important role in growth [56].”
BackgroundCurrent strategies for the inhibition of hepatic glucose production in type 2 diabetes
Edgerton, D. (2009) · Frontiers in Bioscience · doi:10.2741/3301 · Cited by 54
“The direct effect results from the interaction of the hormone with its hepatic receptor and involves the classic Akt signaling cascade (81).”
BackgroundFeng, X., Tian-Zhan, W. A. N. G., Leng, J., Chen, Y., Ji-Bo, L. I. U., Liu, Y., & Wang, W. (2012) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120107 · Cited by 56
Yang, L. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.621 · Cited by 56
“IRS1 plays a significant role in the process where insulin and IGF-1 are transferring signals to intracellular signal pathways PI3K/Akt and ErkMAPK (13).”
BackgroundRodriguez‐Araujo, G., Nakagami, H., Hayashi, H., Mori, M., Shiuchi, T., Minokoshi, Y., Nakaoka, Y., Takami, Y., Komuro, I., Morishita, R., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1198-8 · Cited by 55
“Subsequently, based on these findings, we assessed the impact of SNCA treatment on participants in insulin signaling pathways to examine whether these molecules could be potential upstream players for the effects of SNCA [18].”
BackgroundZhang, C., Chen, X.-H., Wang, B., Liu, F., Chi, X., Tong, M., Ni, Y., Chen, R., & Guo, X. (2008) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.9 · Cited by 56
STAT3 Sensitizes Insulin Signaling by Negatively Regulating Glycogen Synthase Kinase-3β
Moh, A., Zhang, W., Yu, S., Wang, J., Xu, X., Li, J., & Fu, X.-Y. (2008) · Diabetes · doi:10.2337/db06-1582 · Cited by 54
“Physiologically, insulin signals through a pathway involving protein kinases including, but not limited to, phosphatidylinositol 3-kinase, AKT or protein kinase B (PKB), and glycogen synthase kinase (GSK)-3 (the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway) (1).”
BackgroundAndrisse, S., Childress, S., Ma, Y., Billings, K., Chen, Y., Xue, P., Stewart, A. N., Sonko, M. L., Wolfe, A., & Wu, S. (2016) · Endocrinology · doi:10.1210/en.2016-1553 · Cited by 58
Liu, J., Duan, Y., Fu, J. H., & Wang, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00130 · Cited by 58
Home, P. D., & Pacini, G. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00761.x · Cited by 54
Luo, Z., Fu, C., Li, T., Gao, Q., Miao, D., Xu, J., & Zhao, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07630 · Cited by 55
Penna, C. R. R., Tullio, F., Perrelli, M. G., Moro, F., Abbadessa, G., Piccione, F. M., Carriero, V. M. A., Racca, S., & Pagliaro, P. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0143-y · Cited by 53
“[12, 56 ]. After ischemia/reperfusion, Akt phosphorylation is, in particular, low in more vulnerable hearts (i.e., long_ND group).”
Agonism and Antagonism at the Insulin Receptor
Knudsen, L., Hansen, B. F., Jensen, P., Pedersen, T. Å., Vestergaard, K., Schäffer, L., Blagoev, B., Oleksiewicz, M. B., Kiselyov, V. V., & MEYTS, P. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051972 · Cited by 53
“The agonistic effects of S961 were observed in 3 independent cell lines, with complete concordance between mitogenicity (3H-thymidine incorporation) and phosphorylation of the IR and Akt.”
BackgroundInfluentialZhang, H., Du, Z., Dong, J., Wang, H.-X., Shi, H., Wang, N., Wang, S., & Li, H. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-517 · Cited by 63
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
Chun, K., Choi, K., Lee, D.-H., Jung, Y., Henry, R. R., Ciaraldi, T. P., & Kim, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00538.2010 · Cited by 57
“The phosphorylated insulin receptor binds to and activates insulin receptor substrate-1 (IRS-1), resulting in activation of the phosphoinositide 3-kinase (PI3K)/Akt pathway (35, 38), leading to increased glucose transport.”
BackgroundShen, L., Haas, M., Wang, D. Q. ‐., May-Zhang, A. A., Lo, C. C., Obici, S., Tso, P., Woods, S. C., & Liu, M. (2015) · Physiological Reports · doi:10.14814/phy2.12543 · Cited by 57
“Stimulation of glucose uptake in skeletal muscle is one of the most important processes regulated by insulin (Taniguchi et al. 2006).”
BackgroundEmerging roles for the ubiquitin-proteasome system and autophagy in pancreatic β-cells
Hartley, T., Brumell, J. H., & Volchuk, A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90538.2008 · Cited by 67
“The -cell is the only source of circulating insulin, which is essential for both stimulating peripheral tissue glucose uptake and inhibiting liver glucose production, among other metabolic effects (112).”
Effects of phoxim on nutrient metabolism and insulin signaling pathway in silkworm midgut
Li, F., Hu, J., Tian, J., Xu, K., Ni, M., Wang, B., Shen, W., & Li, B. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.12.032 · Cited by 55
Semple, R. K. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1131 · Cited by 63
Guo, S., Zhang, M., & Liu, T. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00031 · Cited by 62
Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice
Wang, P., Su, C., Feng, H., Chen, X., Dong, Y., Rao, Y., Ren, Y., Yang, J.-D., Shi, J., Tian, J., et al. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016688025 · Cited by 57
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP
Valentino, E., Bellazzo, A., Minin, G. D., Sicari, D., Apollonio, M., Scognamiglio, G., Bonito, M. D., Botti, G., Sal, G. D., & Collavin, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700996114 · Cited by 54
“Because insulin can also trigger activation of the Ras/MAPK cascade (5, 9), we monitored ERK phosphorylation as a readout of this pathway.”
BackgroundMethodde la Rosa, I. A., Escudero‐Contreras, A., Rodríguez‐Cuenca, S., Ruiz-Ponce, M., Jiménez, Y., Ruiz‐Limón, P., Pérez‐Sánchez, C., Ábalos‐Aguilera, M. C., Cecchi, I., Ortega, R., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12743 · Cited by 58
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 59
“Additionally, insulin activates non-IRS-dependent signaling pathways by other substrates such as heterotrimeric G proteins and the son of sevenless (SOS) growth factor [20].”
BackgroundNetwork Pharmacology-Based Dissection of the Anti-diabetic Mechanism of Lobelia chinensis
Ge, Q., Chen, L., Yuan, Y., Liu, L., Feng, F., Lv, P., Ma, S., Chen, K., & Yao, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00347 · Cited by 60
“Among them, there are lots of target proteins involved in the PI3K–AKT signaling pathway, insulin signaling pathway, and TNF signaling pathway, which play an explicit role in maintaining insulin secretion, glucose homeostasis, and inflammation (Taniguchi et al., 2006).”
BackgroundLee, S., & Yoon, K. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0163 · Cited by 68
“These findings were the cornerstone of insulinrelated studies and were followed by a tremendous amount of research on insulin signaling and insulin resistance [34,35].”
BackgroundInsulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes
Basuki, W., Hiromura, M., & Sakurai, H. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.12.015 · Cited by 56
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance
Caturano, A., Galiero, R., Vetrano, E., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., & Sasso, F. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158369 · Cited by 63
“Activated AKT then phosphorylates a variety of downstream targets involved in glucose uptake, glycogen synthesis, and lipid metabolism [89,90].”
BackgroundMorcavallo, A., Gaspari, M., Pandini, G., Palummo, A., Cuda, G., Larsen, M. R., Vigneri, R., & Belfiore, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0484 · Cited by 54
Modulation of the action of insulin by angiotensin-(1–7)
Dominici, F. P., Burghi, V., Muñoz, M. C., & Giani, J. F. (2014) · Clinical Science · doi:10.1042/cs20130333 · Cited by 52
Lashinger, L. M., Malone, L. M., Brown, G. W., Daniels, E. A., Goldberg, J. A., Otto, G. M., Fischer, S. M., & Hursting, S. D. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0023 · Cited by 53
“IGF-1 exerts its effects on cellular growth and metabolism, at least partially through activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway (13, 14).”
BackgroundRegulation of Epithelial-Mesenchymal Transition in Palatal Fusion
Wen-li, Y., Ruest, L. B., & Svoboda, K. K. H. (2009) · Experimental Biology and Medicine · doi:10.3181/0812-mr-365 · Cited by 54
“It was suggested both PI3K and p38 MAPK can modify the Smad protein activity (56, 95).”
BackgroundLie, S., Morrison, J. L., Williams-Wyss, O., Suter, C. M., Humphreys, D. T., Ozanne, S. E., Zhang, S., MacLaughlin, S. M., Kleemann, D. O., Walker, S. K., et al. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.109751 · Cited by 60
“Phosphorylated PRKCZ and TBC1D4 each play a major role in the translocation of the solute carrier family 2 (facilitated glucose transporter) member 4 (SLC2A4) to the plasma membrane to facilitate glucose uptake into skeletal muscle [14].”
BackgroundThe importance of synthetic drugs for type 2 diabetes drug discovery
Safavi, M., Foroumadi, A., & Abdollahi, M. R. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.837883 · Cited by 60
“The actions of insulin are initiated when the receptor is bound to the extracellular a subunits, causing phosphorylation of intracellular tyrosine kinase domain of the b subunits and inducing a conformational change [46-48].”
BackgroundNonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
Cazzo, E., Pareja, J. C., & Chaim, É. A. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0306311216 · Cited by 59
IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK
Wolters, T. L. C., Netea, M. G., Hermus, A. R. M. M., Smit, J. W. A., & Netea-Maier, R. T. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0062 · Cited by 55
Raun, S. H., Ali, M., Kjøbsted, R., Møller, L. L. V., Federspiel, M. A., Richter, E. A., Jensen, T. E., & Sylow, L. (2018) · The Journal of Physiology · doi:10.1113/jp275602 · Cited by 52
“Insulin regulates many biological functions in skeletal muscle and stimulation of skeletal muscle glucose uptake is one of the most important (Taniguchi et al. 2006).”
BackgroundAltered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2
Matsuo, K., Delibegovic, M., Matsuo, I., Nagata, N., Liu, S., Bettaieb, A., Xi, Y., Araki, K., Yang, W., Kahn, B. B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153734 · Cited by 52
Brummer, T., Schmitz‐Peiffer, C., & Daly, R. J. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07865.x · Cited by 74
Impaired Insulin Signaling and Mechanisms of Memory Loss
Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 57
Serum response factor regulates bone formation via IGF-1 and Runx2 signals
Chen, J., Yuan, K., Mao, X., Miano, J. M., Wu, H., & Chen, Y. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1607 · Cited by 52
“The activation of Akt and ERK signaling pathways is crucial for osteogenic differentiation from uncommitted mesenchymal precursor cells and for maturation of committed osteoblasts.((12,52)) SRF deficiency selectively inhibited IGF-1– activated PI3K/Akt but not ERK signaling in calvarial cells (Fig.”
BackgroundNellemann, B., Vendelbo, M. H., Nielsen, T. S., Bak, A. M., Høgild, M. L., Pedersen, S. B., Biensø, R. S., Pilegaard, H., Møller, N., Jessen, N., et al. (2013) · Acta Physiologica · doi:10.1111/apha.12183 · Cited by 55
“Activation of the serine/threonine kinase Akt is crucial for most of the metabolic actions of insulin (Taniguchi et al. 2006).”
BackgroundIkeda, H., Shiojima, I., Ozasa, Y., Yoshida, M., Holzenberger, M., Kahn, C. R., Walsh, K., Igarashi, T., Abel, E. D., & Komuro, I. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.028 · Cited by 50
“These receptors are highly homologous and exist as α2β2 heterodimers, with two extracellular ligand-binding α subunits and two transmembrane β subunits that contain tyrosine kinase domains [28].”
Self-citationEndothelial IGF-1 Receptor Signalling in Diabetes and Insulin Resistance
Cubbon, R. M., Kearney, M. T., & Wheatcroft, S. B. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.11.009 · Cited by 52
“A key feature of the disease is insulin resistance, defined as an inability of insulin to appropriately activate its complex intracellular signaling network, and subsequently promote metabolic effects, such as glucose disposal [17].”
BackgroundRole of insulin receptor substrates in the progression of hepatocellular carcinoma
Sakurai, Y., Kubota, N., Takamoto, I., Obata, A., Iwamoto, M., Hayashi, T., Aihara, M., Kubota, T., Nishihara, H., & Kadowaki, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03299-3 · Cited by 51
TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
Hwang, J.-H., Kim, A. R., Kim, K. M., Park, J. I., Oh, H. T., Moon, S. A., Byun, M. R., Jeong, H., Kim, H. K., Yaffe, M. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08287-x · Cited by 58
Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance?
Genders, A. J., Holloway, G. P., & Bishop, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186948 · Cited by 51
“Insulin then activates a number of different signalling pathways in various tissues [1], with the primary aim of facilitating nutrient uptake and storage in tissues, particularly skeletal muscle, liver, and adipose tissue.”
BackgroundZhong, L., Liu, H., Zhang, H., Zhang, W., Li, M., Ya, H., Yao, J., Huang, X., Geng, Y., Chen, D., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.880513 · Cited by 58
“Insulin secreted by the organism binds to insulin receptors on the cell surface to phosphorylate insulin receptor substrate protein (IRS), which in turn activates the PI3K/Akt signaling pathway (Taniguchi et al., 2006).”
Background
Metadata
- Authors
- Taniguchi, C. M., Emanuelli, B., & Kahn, C. R.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 85-96
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1998493448
- Cited by
- 2,760
- References
- 129
- Citations by year
- 2026: 87 · 2025: 91 · 2024: 97 · 2023: 96 · 2022: 149 · 2021: 144 · 2020: 147 · 2019: 118 · 2018: 156 · 2017: 136 · 2016: 148 · 2015: 177 · 2014: 188 · 2013: 189 · 2012: 181
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- Diabetes Research Center
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK031036)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- critical nodes, insulin signaling, signaling networks, signaling crosstalk, signal divergence, insulin resistance, insulin action
- MeSH terms
- Animals, Humans, Insulin, Receptor, Insulin, Signal Transduction, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.